elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Tyrosine-kinase inhibitor
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Tyrosine-kinase inhibitor
RIS
0.000
(Research Intensity Score)
Papers
37
Top papers
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
2023 · 737 citations
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020 · 1525 citations
Lung Cancer in Nonsmoking Individuals
2025 · 30 citations
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 · 3506 citations
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
2020 · 280 citations
Newest papers
Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma
2026 · 2 citations
Gastrointestinal Stromal Tumors: Molecular Mechanisms of Drug Resistance and Advances in Therapeutic Strategies
2026 · 2 citations
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801)
2026 · 1 citations
A phase 2 randomized trial of radium-223 dichloride and cabozantinib in patients (pts) with renal cell carcinoma (RCC) with bone metastases (BM): RADICAL (Alliance A031801).
2026 · 1 citations
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST
2026
A sample from the 37 top papers behind Tyrosine-kinase inhibitor.
Create a free account to browse them all →
Tyrosine-kinase inhibitor's history
Research intensity over time
Explore Tyrosine-kinase inhibitor's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Tyrosine-kinase inhibitor's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link